The results of the PK-PD research show that chlorogenic acid, cryptochlorogenic acid, and neochlorogenic acid can treat RA by inhibiting the secretion of IL-1β, RF, and TNF-α [24,37]. This evidence concerns the gene IL1B and rheumatoid arthritis.